Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

NCT07227818 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

560

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: NBI-1117568
DRUG: Placebo

Sponsor

Neurocrine Biosciences